Using CRISPR gene editing, a team from Children’s Hospital of Philadelphia (CHOP) and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth.
This proof-of-concept study, published today in Science Translational Medicine, showed that in uteroediting could be a promising new approach for treating lung diseases before birth.
“The developing fetus has many innate properties that make it an attractive recipient for therapeutic gene editing,” said study co-leader William H. Peranteau, MD, an investigator at CHOP’s Center for Fetal Research, and a pediatric and fetal surgeon in CHOP’s Center for Fetal Diagnosis and Treatment. “Furthermore, the ability to cure or mitigate a disease via gene editing in mid- to late gestation before birth and the onset of irreversible pathology is very exciting. This is particularly true for diseases that affect the lungs, whose function becomes dramatically more important at the time of birth.”
The lung conditions the team is hoping to solve — congenital diseases such as surfactant protein deficiency, cystic fibrosis, and alpha-1 antitrypsin — are characterized by respiratory failure at birth or chronic lung disease with few options for therapies. About 22 percent of all pediatric hospital admissions are because of respiratory disorders, and congenital causes of respiratory diseases are often lethal, despite advances in care and a deeper understanding of their molecular causes. Because the lung is a barrier organ in direct contact with the outside environment, targeted delivery to correct defective genes is an attractive therapy.
“We wanted to know if this could work at all,” said study co-leader Edward E. Morrisey, PhD, a professor of Cardiovascular Medicine in the Perelman School of Medicine at the University of Pennsylvania. “The trick was how to direct the gene-editing machinery to target cells that line the airways of the lungs.”
The researchers showed that precisely timed in utero delivery of CRISPR gene-editing reagents to the amniotic fluid during fetal development resulted in targeted changes in the lungs of mice. They introduced the gene editors into developing mice four days before birth, which is analogous to the third trimester in humans.
The cells that showed the highest percentage of editing were alveolar epithelial cells and airway secretory cells lining lung airways. In 2018, a team led by Morrisey identified the alveolar epithelial progenitor (AEP) lineage, which is embedded in a larger population of cells called alveolar type 2 cells. These cells generate pulmonary surfactant, which reduces surface tension in the lungs and keeps them from collapsing with every breath. AEPs are a stable cell type in the lung and turn over very slowly, but replicate rapidly after injury to regenerate the lining of the alveoli and restore gas exchange.
In a second experiment, the researchers used prenatal gene editing to reduce the severity of an interstitial lung disease, surfactant protein C (SFTPC) deficiency, in a mouse model that has a common disease-causing mutation found in the human SFTPC gene. One hundred percent of untreated mice with this mutation die from respiratory failure within hours of birth. In contrast, prenatal gene editing to inactivate the mutant Sftpc gene resulted in improved lung morphology and survival of over 22 percent of the animals.
Future studies will be directed toward increasing the efficiency of the gene editing in the epithelial lining of lungs as well as evaluating different mechanisms to deliver gene editing technology to lungs. “Different gene editing techniques are also being explored that may one day be able to correct the exact mutations observed in genetic lung diseases in infants,” Morrisey said.
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- New Antibiotics Produced by Gene Editingon November 29, 2021 at 9:36 am
A novel way of manipulating key assembly line enzymes in bacteria which could pave the way for a new generation of antibiotic treatments has been discovered by researchers.
- Manchester scientists produce new antibiotics by gene editingon November 29, 2021 at 7:41 am
Scientists have discovered a new route to produce complex antibiotics exploiting gene editing to re-programme pathways to future medicines urgently required to combat antimicrobial resistance, treat ...
- New research details using gene editing to make stronger antibioticson November 26, 2021 at 3:46 am
Antibiotic resistance is a massive issue facing humanity right now, but new research is uncovering ways we can use to combat it.
- Good Day BIO: Invite gene editing to the feaston November 24, 2021 at 1:42 pm
Ahead of Thanksgiving, we look at how gene editing is improving our feast tomorrow and all year—plus, giving thanks (and resources) for America’s family caregivers. (696 words, 3 minutes, 28 seconds) ...
- Infecting gut microbes with CRISPR-loaded virus demonstrates potential for microbiome gene editingon November 24, 2021 at 6:33 am
In a first, researchers at the UC San Francisco have successfully used the DNA-editing system, CRISPR to alter the genomes of bacteria living in the guts of mammals, a development which stands to ...
- Global Gene Editing Market Share, Growth, Revenue And Forecast To 2021-2030on November 23, 2021 at 7:39 pm
Get up to 33 off on ALL market research reports at Research Company s holiday sale buy now https www thebusinessresearchcompany com global market reports Gene Editing Global Market Report 2021 COVID ...
- 7 Top Gene-Editing Stocks to Buyon November 23, 2021 at 8:00 am
Analysts recommend these gene-editing stocks. Gene therapy and gene editing are on the cutting edge of modern biotechnology. Gene therapies are used to correct genetic abnormalities by ...
- As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer'son November 22, 2021 at 6:50 am
Scientist David Liu has developed two ways to edit human DNA. He's testing whether they can be used to prevent Alzheimer's disease.
- CRISPR gene editing causes whole chromosome losson November 19, 2021 at 3:23 am
In another of a long line of studies showing unintended effects of gene editing, the CRISPR-Cas gene editing tool has been found to cause the loss of whole chromosomes and genomic instability in mouse ...
- New findings on the link between CRISPR gene-editing and mutated cancer cellson November 18, 2021 at 7:28 am
A protein that protects cells from DNA damage, p53, is activated during gene editing using the CRISPR technique. Consequently, cells with mutated p53 have a survival advantage, which can cause cancer.
via Bing News